Abstract Cardiotoxicity is an important complication associated with chemotherapy for the treatment of cancer patients. Its diagnosis is based on serial assessment of left ventricular ejection fraction (LVEF), however the LVEF decrease occurs late in the evolution of this condition. Thus, alternative non-invasive methods for early diagnosis of cardiotoxicity have emerged with this purpose, specially in echocardiography and nuclear medicine. The assessment of cardiac sympathetic function using 123I-MIBG scan arises as a promising tool, since adrenergic damage appears to precede […]
